Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
2.
Toxins (Basel) ; 13(5)2021 04 27.
Artigo em Inglês | MEDLINE | ID: mdl-33925470

RESUMO

This case-control study adds to the growing body of knowledge on the medical, nutritional, and environmental factors associated with Nodding Syndrome (NS), a seizure disorder of children and adolescents in northern Uganda. Past research described a significant association between NS and prior history of measles infection, dependence on emergency food and, at head nodding onset, subsistence on moldy maize, which has the potential to harbor mycotoxins. We used LC-MS/MS to screen for current mycotoxin loads by evaluating nine analytes in urine samples from age-and-gender matched NS cases (n = 50) and Community Controls (CC, n = 50). The presence of the three mycotoxins identified in the screening was not significantly different between the two groups, so samples were combined to generate an overall view of exposure in this community during the study. Compared against subsequently run standards, α-zearalenol (43 ± 103 µg/L in 15 samples > limit of quantitation (LOQ); 0 (0/359) µg/L), T-2 toxin (39 ± 81 µg/L in 72 samples > LOQ; 0 (0/425) µg/L) and aflatoxin M1 (4 ± 10 µg/L in 15 samples > LOQ; 0 (0/45) µg/L) were detected and calculated as the average concentration ± SD; median (min/max). Ninety-five percent of the samples had at least one urinary mycotoxin; 87% were positive for two of the three compounds detected. While mycotoxin loads at NS onset years ago are and will remain unknown, this study showed that children with and without NS currently harbor foodborne mycotoxins, including those associated with maize.


Assuntos
Micotoxinas/urina , Síndrome do Cabeceio/urina , Adolescente , Aflatoxinas/efeitos adversos , Aflatoxinas/urina , Estudos de Casos e Controles , Criança , Desenvolvimento Infantil/efeitos dos fármacos , Fenômenos Fisiológicos da Nutrição Infantil/efeitos dos fármacos , Pré-Escolar , Feminino , Microbiologia de Alimentos , Humanos , Masculino , Micotoxinas/efeitos adversos , Síndrome do Cabeceio/etiologia , Uganda , Zea mays/efeitos adversos , Zea mays/microbiologia , Zeranol/efeitos adversos , Zeranol/análogos & derivados , Zeranol/urina
3.
Crit Rev Food Sci Nutr ; 59(13): 2052-2060, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-29405739

RESUMO

According to the Academy of Nutrition and Dietetics' influential position statement on vegetarianism, meat and seafood can be replaced with milk, soy/legumes, and eggs without any negative effects in children. The United States Department of Agriculture endorses a similar view. The present paper argues that the Academy of Nutrition and Dietetics ignores or gives short shrift to direct and indirect evidence that vegetarianism may be associated with serious risks for brain and body development in fetuses and children. Regular supplementation with iron, zinc, and B12 will not mitigate all of these risks. Consequently, we cannot say decisively that vegetarianism or veganism is safe for children.


Assuntos
Dieta Vegetariana , Encéfalo/metabolismo , Criança , Desenvolvimento Infantil/efeitos dos fármacos , Saúde da Criança , Fenômenos Fisiológicos da Nutrição Infantil/efeitos dos fármacos , Pré-Escolar , Creatina/administração & dosagem , Creatina/deficiência , Suplementos Nutricionais , Dietética , Ovos , Ácidos Graxos Ômega-3/administração & dosagem , Ácidos Graxos Ômega-3/deficiência , Ácidos Graxos Ômega-6/administração & dosagem , Ácidos Graxos Ômega-6/deficiência , Feminino , Desenvolvimento Fetal/efeitos dos fármacos , Feto/metabolismo , Humanos , Lactente , Ferro/administração & dosagem , Deficiências de Ferro , Saúde Mental , Necessidades Nutricionais , Estado Nutricional , Fitoestrógenos/administração & dosagem , Gravidez , Glycine max , Taurina/administração & dosagem , Taurina/deficiência , Estados Unidos , United States Department of Agriculture , Vitamina B 12/administração & dosagem , Deficiência de Vitamina B 12 , Zinco/administração & dosagem , Zinco/deficiência
4.
Nutrients ; 10(3)2018 03 13.
Artigo em Inglês | MEDLINE | ID: mdl-29533998

RESUMO

Vitamin D deficiency is highly prevalent in newly settled refugees in Western Australia (WA). If adherence to daily vitamin D therapy is problematic, depot therapy is a therapeutic alternative. The aim of this study was to compare daily versus depot treatment and factors influencing the therapeutic outcome. Newly settled refugees (n = 151) with 25(OH)D levels less than 78 nmol/L were randomised to receive daily or depot vitamin D therapy with eight weekly interval follow up to 40 weeks. Biochemical and clinical parameters were collected at each visit. Generalized Linear Mixed Models (GLMM) examined the longitudinal changes over time controlling for confounders including age, gender, treatment arm, season, country of refuge/origin and sun exposure score. Participants were aged 5.5 months to 16.0 years (75 males, 83 females). Both treatment groups achieved vitamin D sufficiency. The daily treatment group had significantly higher 25(OH)D levels at each visit post baseline and a higher proportion of participants with levels above 50 nmol/L at all time points. Time, treatment group, calcium and sun exposure score were significant predictors of 25(OH)D serum levels. Depot vitamin D therapy is an alternative to daily treatment in this at-risk group of children and adolescents in whom treatment adherence is problematic.


Assuntos
Fenômenos Fisiológicos da Nutrição Infantil/efeitos dos fármacos , Colecalciferol/administração & dosagem , Deficiência de Vitamina D/tratamento farmacológico , Adolescente , Fenômenos Fisiológicos da Nutrição do Adolescente/efeitos dos fármacos , Fenômenos Fisiológicos da Nutrição do Adolescente/etnologia , África/etnologia , Ásia/etnologia , Calcifediol/sangue , Criança , Fenômenos Fisiológicos da Nutrição Infantil/etnologia , Pré-Escolar , Colecalciferol/uso terapêutico , Estudos de Coortes , Preparações de Ação Retardada/administração & dosagem , Preparações de Ação Retardada/uso terapêutico , Suplementos Nutricionais , Esquema de Medicação , Feminino , Seguimentos , Humanos , Lactente , Fenômenos Fisiológicos da Nutrição do Lactente/efeitos dos fármacos , Fenômenos Fisiológicos da Nutrição do Lactente/etnologia , Perda de Seguimento , Masculino , Oriente Médio/etnologia , Cooperação do Paciente/etnologia , Refugiados , Deficiência de Vitamina D/sangue , Deficiência de Vitamina D/dietoterapia , Deficiência de Vitamina D/etnologia , Austrália Ocidental
5.
Nutr Neurosci ; 21(3): 202-209, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27924679

RESUMO

OBJECTIVES: Previous studies have shown that serum levels of vitamin D were lower in attention deficit hyperactivity disorder (ADHD) children compared to healthy controls. The aim of the study was to determine the effect of vitamin D supplementation as adjunctive therapy to methylphenidate on symptoms of children with ADHD. METHODS: Sixty-two children aged 5-12 years with a diagnosis of ADHD based on DSM-IV criteria were randomly assigned into two groups to receive either 2000IU vitamin D or placebo in addition to methylphenidate for 8 weeks. Symptoms severity was assessed by Conner's Parent Rating Scale-Revised[S] (CPRS), ADHD rating scale-IV (ADHD-RS), and Weekly Parent Ratings of Evening and Morning Behavior (WPREMB) at weeks 0, 4, and 8. Serum levels of 25(OH)D were measured at baseline and after 8 weeks. Anthropometric variables, dietary intake, physical activity, sun exposure, and side effects were assessed. RESULTS: Fifty-four participants completed the trial. After 8 weeks of supplementation, serum levels of 25(OH)D significantly increased in the vitamin D group. ADHD symptoms decreased significantly in both groups (P < 0.05). Evening symptoms and total score of WPREMB scale were significantly different at weeks 4 and 8 between the two groups (P = 0.013, 0.016, respectively), but no differences were found in symptoms by CPRS and ADHD-RS scales. DISCUSSION: Vitamin D supplementation as adjunctive therapy to methylphenidate improved ADHD evening symptoms. Future research is needed to clarify vitamin D effects as monotherapy in ADHD and its mechanism. The trial was registered in www.irct.ir is (IRCT201404222394N10).


Assuntos
Transtorno do Deficit de Atenção com Hiperatividade/dietoterapia , Transtorno do Deficit de Atenção com Hiperatividade/tratamento farmacológico , Fenômenos Fisiológicos da Nutrição Infantil , Suplementos Nutricionais , Inibidores da Captação de Dopamina/uso terapêutico , Metilfenidato/uso terapêutico , Vitamina D/uso terapêutico , Atividades Cotidianas , Transtorno do Deficit de Atenção com Hiperatividade/complicações , Transtorno do Deficit de Atenção com Hiperatividade/fisiopatologia , Calcifediol/sangue , Criança , Fenômenos Fisiológicos da Nutrição Infantil/efeitos dos fármacos , Pré-Escolar , Terapia Combinada/efeitos adversos , Manual Diagnóstico e Estatístico de Transtornos Mentais , Suplementos Nutricionais/efeitos adversos , Inibidores da Captação de Dopamina/efeitos adversos , Método Duplo-Cego , Feminino , Humanos , Irã (Geográfico) , Masculino , Metilfenidato/efeitos adversos , Pais , Índice de Gravidade de Doença , Avaliação de Sintomas , Vitamina D/efeitos adversos , Deficiência de Vitamina D/sangue , Deficiência de Vitamina D/complicações , Deficiência de Vitamina D/dietoterapia , Deficiência de Vitamina D/fisiopatologia
6.
Pediatr Diabetes ; 18(4): 255-261, 2017 06.
Artigo em Inglês | MEDLINE | ID: mdl-28425167

RESUMO

Continuous subcutaneous insulin infusion (CSII) is a very common therapy for children with type 1 diabetes. Due to physiological differences they have other requirements for their insulin pump than adults. The main difference is the need for very low basal rates. Even though most available insulin pumps reach a high accuracy at usual basal rates, accuracy decreases for lower rates. In addition, the lowest delivered amount at 1 time is limiting the fine tuning of the basal rate as well as the option for temporary basal rates. Alarms in case of occlusions depend on accumulation of a certain amount of insulin in the catheter, and therefore the time until such an alarm is triggered is much longer with lower basal rates. Accordingly, the risk for hyperglycemia developing into diabetic ketoacidosis increases. The availability of bolus advisors facilitates the calculation of meal and correction boluses for children and their parents. However, there are some differences between the calculators, and the settings that the calculation is based on are very important. Better connectivity, for example with a system for continuous glucose monitoring, might help to further increase safety in the use of CSII in children. When selecting an insulin pump for a child, the features and characteristics of available pumps should be properly compared to ensure an effective and safe therapy.


Assuntos
Diabetes Mellitus Tipo 1/tratamento farmacológico , Hiperglicemia/prevenção & controle , Hipoglicemia/prevenção & controle , Hipoglicemiantes/administração & dosagem , Sistemas de Infusão de Insulina , Insulina/administração & dosagem , Medicina de Precisão , Adolescente , Comportamento do Adolescente/efeitos dos fármacos , Fenômenos Fisiológicos da Nutrição do Adolescente/efeitos dos fármacos , Criança , Comportamento Infantil/efeitos dos fármacos , Fenômenos Fisiológicos da Nutrição Infantil/efeitos dos fármacos , Terapia Combinada/efeitos adversos , Diabetes Mellitus Tipo 1/sangue , Diabetes Mellitus Tipo 1/complicações , Diabetes Mellitus Tipo 1/terapia , Cetoacidose Diabética/etiologia , Cetoacidose Diabética/fisiopatologia , Cetoacidose Diabética/prevenção & controle , Dieta para Diabéticos , Exercício Físico , Humanos , Hiperglicemia/fisiopatologia , Hipoglicemia/induzido quimicamente , Hipoglicemia/fisiopatologia , Hipoglicemiantes/efeitos adversos , Hipoglicemiantes/uso terapêutico , Infusões Subcutâneas , Insulina/efeitos adversos , Insulina/uso terapêutico , Sistemas de Infusão de Insulina/efeitos adversos , Índice de Gravidade de Doença
7.
Int J Obes (Lond) ; 40(6): 1018-25, 2016 06.
Artigo em Inglês | MEDLINE | ID: mdl-26975442

RESUMO

BACKGROUND: Previous studies suggest that high protein intake in infancy leads to a higher body mass index (BMI) in later childhood. We examined the associations of total, animal and vegetable protein intake in early childhood with detailed measures of body composition at the age of 6 years. METHODS: This study was performed in 2911 children participating in a population-based cohort study. Protein intake at the age of 1 year was assessed with a validated food-frequency questionnaire and was adjusted for total energy intake. At the children's age of 6 years, we measured their anthropometrics and body fat (with dual-energy X-ray absorptiometry). We calculated age- and sex-specific s.d. scores for BMI, fat mass index (FMI) and fat-free mass index (FFMI). RESULTS: After adjustment for confounders, a 10 g per day higher total protein intake at 1 year of age was associated with a 0.05 s.d. (95% confidence interval (CI) 0.00, 0.09) higher BMI at age 6. This association was fully driven by a higher FMI (0.06 s.d. (95%CI 0.01, 0.11)) and not FFMI (-0.01 s.d. (95%CI -0.06, 0.05)). The associations of protein intake with FMI at 6 years remained significant after adjustment for BMI at the age of 1 year. Additional analyses showed that the associations of protein intake with FMI were stronger in girls than in boys (P for interaction=0.03), stronger among children who had catch-up growth in the first year of life (P for interaction<0.01) and stronger for intake of animal protein (both dairy and non-dairy protein) than protein from vegetable sources. CONCLUSIONS: Our results suggest that high protein intake in early childhood is associated with higher body fat mass, but not fat-free mass. Future studies are needed to investigate whether these changes persist into adulthood and to examine the optimal range of protein intake for infants and young children.


Assuntos
Composição Corporal/efeitos dos fármacos , Fenômenos Fisiológicos da Nutrição Infantil/efeitos dos fármacos , Proteínas Alimentares/administração & dosagem , Proteínas Alimentares/farmacologia , Índice de Massa Corporal , Criança , Ingestão de Energia , Comportamento Alimentar , Feminino , Humanos , Masculino , Países Baixos/epidemiologia , Avaliação Nutricional , Obesidade Infantil/epidemiologia , Obesidade Infantil/prevenção & controle , Estudos Prospectivos
8.
Curr Opin Clin Nutr Metab Care ; 18(2): 113-7, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25581037

RESUMO

PURPOSE OF REVIEW: The impact of fatty acids in early nutrition on later body composition and obesity risk remains elusive. Aim of this review was to summarize and discuss recent studies on the role of early supply with long-chain polyunsaturated fatty acids (LCPUFAs) through maternal nutrition during pregnancy and lactation for later offspring obesity. RECENT FINDINGS: Recent human studies, either interventional or observational, investigating the role of dietary fatty acids, in particular of LCPUFAs, on body composition and later obesity risk provide inconsistent results concerning BMI as well as fat mass development in the offspring. A recent meta-analysis of randomized controlled trials found no significant effect of maternal supplementation with n-3 LCPUFA on BMI in both preschool and school-aged children. SUMMARY: There is currently no conclusive evidence that dietary intervention to modify fat intake during pregnancy and lactation is a reasonable strategy to prevent childhood obesity in humans, but more research is clearly needed to address this issue.


Assuntos
Composição Corporal/efeitos dos fármacos , Fenômenos Fisiológicos da Nutrição Infantil/efeitos dos fármacos , Ácidos Graxos Insaturados/administração & dosagem , Fenômenos Fisiológicos da Nutrição Materna/efeitos dos fármacos , Obesidade/etiologia , Tecido Adiposo/crescimento & desenvolvimento , Índice de Massa Corporal , Pré-Escolar , Suplementos Nutricionais , Ácidos Graxos Insaturados/efeitos adversos , Feminino , Humanos , Lactação , Estudos Observacionais como Assunto , Gravidez , Ensaios Clínicos Controlados Aleatórios como Assunto , Risco
9.
Diabetes Obes Metab ; 17(4): 363-70, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25483291

RESUMO

AIMS: To investigate the effects of metformin on appetite and energy intake in obese children with hyperinsulinaemia. METHODS: We conducted a 6-month randomized, double-blind, placebo-controlled trial to evaluate the effects of metformin 1000 mg twice daily on body weight and energy balance in 100 obese children with hyperinsulinaemia aged 6-12 years. The children ate ad libitum from standardized food arrays on two separate occasions before and after 6 months of study medication. The first test meal was consumed after an overnight fast. The second was preceded by a pre-meal load. For each test meal, energy intake was recorded, and the children completed scales of hunger, fullness and desire to eat. RESULTS: Data from the meal studies at baseline and after treatment with study medication were available for 84 children (metformin-treated, n = 45; placebo-treated, n = 39). Compared with placebo, metformin treatment elicited significant reductions from baseline in adjusted mean ± standard error of the mean energy intake after the pre-meal load (metformin: -104.7 ± 83.8 kcal vs. placebo: +144.2 ± 96.9 kcal; p = 0.034) independently of changes in body composition. Metformin also significantly decreased ratings of hunger (-1.5 ± 5.6 vs. +18.6 ± 6.3; p = 0.013) and increased ratings of fullness (+10.1 ± 6.2 vs. -12.8 ± 7.0; p = 0.01) after the pre-meal load. CONCLUSIONS: These data suggest that decreased perceived hunger resulting in diminished food intake are among the mechanisms by which metformin treatment reduces body weight in overweight children with hyperinsulinaemia.


Assuntos
Depressores do Apetite/uso terapêutico , Fenômenos Fisiológicos da Nutrição Infantil/efeitos dos fármacos , Ingestão de Energia/efeitos dos fármacos , Hipoglicemiantes/uso terapêutico , Metformina/uso terapêutico , Obesidade Infantil/tratamento farmacológico , Resposta de Saciedade/efeitos dos fármacos , Depressores do Apetite/efeitos adversos , Índice de Massa Corporal , Criança , Comportamento Infantil/efeitos dos fármacos , Terapia Combinada/efeitos adversos , Dieta Redutora , Método Duplo-Cego , Feminino , Humanos , Hiperinsulinismo/etiologia , Hiperinsulinismo/prevenção & controle , Hipoglicemiantes/efeitos adversos , Estilo de Vida , Masculino , Metformina/efeitos adversos , Atividade Motora , National Institutes of Health (U.S.) , Uso Off-Label , Pais/educação , Educação de Pacientes como Assunto , Obesidade Infantil/sangue , Obesidade Infantil/fisiopatologia , Obesidade Infantil/terapia , Estados Unidos , Redução de Peso/efeitos dos fármacos
10.
J Endocrinol Invest ; 35(2): 160-8, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21623150

RESUMO

AIM: To evaluate if nutritional intakes and lipid profile fulfill international guidelines and recommendations before and after a structured dietician training to a Mediterranean- style diet in an Italian pediatric population with Type 1 diabetes. METHODS: A 6-month prospective cohort study. Baseline and after-intervention nutritional intakes, lipid profile, glycated hemoglobin (HbA(1c)), and clinical parameters of 96 children and adolescents with Type 1 diabetes were assessed. A comparative computerized system which was approved and validated by the Italian Diabetologist Association was used to define the amounts of nutrients. RESULTS: At baseline mean daily dietary intakes of carbohydrates, proteins, and lipids were respectively (mean ± SEM) 51.8 ± 0.5, 15.9 ± 0.2, 33.8 ± 0.6%, with a contribution of cholesterol of 248.7 ± 12.5 mg/day. Fiber assumption was 18.0 ± 0.4 g/day. The 64.5% and 29.1% (p<0.0001) of subjects had at least one lipid parameter higher than 75(th) and 95(th) percentiles, respectively, of selected cut points (American Diabetes Association guidelines for total and LDL-cholesterol and American Academy of Pediatrics standards for HDL-cholesterol and triglycerides). Six months after the dietician intervention, dietary lipids and cholesterol decreased (p<0.0001) while fibers (p<0.0001) increased. LDL-cholesterol, non-HDL-cholesterol, and total cholesterol:HDL-cholesterol ratios significantly decreased (p<0.001) with a reduction of rate of subjects with at least one pathological lipid parameter (p<0.01) independently by weight and glucose control. CONCLUSIONS: Italian pediatric subjects with Type 1 diabetes present a balanced diet with exception of lipids intake and a suboptimal lipid profile. A structured dietician training to a Mediterranean-style diet improves the quality of nutrient intakes being followed by a reduction of LDL-cholesterol, non- HDL-cholesterol, and total cholesterol:HDL-cholesterol ratios.


Assuntos
Diabetes Mellitus Tipo 1/sangue , Diabetes Mellitus Tipo 1/dietoterapia , Dieta Mediterrânea , Lipídeos/sangue , Educação de Pacientes como Assunto , Adolescente , Fenômenos Fisiológicos da Nutrição do Adolescente/efeitos dos fármacos , Criança , Fenômenos Fisiológicos da Nutrição Infantil/efeitos dos fármacos , Estudos de Coortes , Diabetes Mellitus Tipo 1/metabolismo , Gorduras na Dieta/farmacologia , Fibras na Dieta/farmacologia , Comportamento Alimentar , Feminino , Humanos , Metabolismo dos Lipídeos/efeitos dos fármacos , Metabolismo dos Lipídeos/fisiologia , Lipídeos/análise , Masculino , Educação de Pacientes como Assunto/métodos , Comportamento de Redução do Risco , Adulto Jovem
11.
Cochrane Database Syst Rev ; (12): CD009085, 2011 Dec 07.
Artigo em Inglês | MEDLINE | ID: mdl-22161444

RESUMO

BACKGROUND: Approximately 600 million children of preschool and school age are anaemic worldwide. It is estimated that half of the cases are due to iron deficiency. Consequences of iron deficiency anaemia during childhood include growth retardation, reduced school achievement, impaired motor and cognitive development, and increased morbidity and mortality. The provision of daily iron supplements is a widely used strategy for improving iron status in children but its effectiveness has been limited due to its side effects, which can include nausea, constipation or staining of the teeth. As a consequence, intermittent iron supplementation (one, two or three times a week on non-consecutive days) has been proposed as an effective and safer alternative to daily supplementation. OBJECTIVES: To assess the effects of intermittent iron supplementation, alone or in combination with other vitamins and minerals, on nutritional and developmental outcomes in children from birth to 12 years of age compared with a placebo, no intervention or daily supplementation. SEARCH METHODS: We searched the following databases on 24 May 2011: CENTRAL (2011, Issue 2), MEDLINE (1948 to May week 2, 2011), EMBASE (1980 to 2011 Week 20), CINAHL (1937 to current), POPLINE (all available years) and WHO International Clinical Trials Registry Platform (ICTRP). On 29 June 2011 we searched all available years in the following databases: SCIELO, LILACS, IBECS and IMBIOMED. We also contacted relevant organisations (on 3 July 2011) to identify ongoing and unpublished studies. SELECTION CRITERIA: Randomised and quasi-randomised trials with either individual or cluster randomisation. Participants were children under the age of 12 years at the time of intervention with no specific health problems. The intervention assessed was intermittent iron supplementation compared with a placebo, no intervention or daily supplementation. DATA COLLECTION AND ANALYSIS: Two authors independently assessed the eligibility of studies against the inclusion criteria, extracted data from included studies and assessed the risk of bias of the included studies. MAIN RESULTS: We included 33 trials, involving 13,114 children (˜49% females) from 20 countries in Latin America, Africa and Asia. The methodological quality of the trials was mixed.Nineteen trials evaluated intermittent iron supplementation versus no intervention or a placebo and 21 studies evaluated intermittent versus daily iron supplementation. Some of these trials contributed data to both comparisons. Iron alone was provided in most of the trials.Fifteen studies included children younger than 60 months; 11 trials included children 60 months and older, and seven studies included children in both age categories. One trial included exclusively females. Seven trials included only anaemic children; three studies assessed only non-anaemic children, and in the rest the baseline prevalence of anaemia ranged from 15% to 90%.In comparison with receiving no intervention or a placebo, children receiving iron supplements intermittently have a lower risk of anaemia (average risk ratio (RR) 0.51, 95% confidence interval (CI) 0.37 to 0.72, ten studies) and iron deficiency (RR 0.24, 95% CI 0.06 to 0.91, three studies) and have higher haemoglobin (mean difference (MD) 5.20 g/L, 95% CI 2.51 to 7.88, 19 studies) and ferritin concentrations (MD 14.17 µg/L, 95% CI 3.53 to 24.81, five studies).Intermittent supplementation was as effective as daily supplementation in improving haemoglobin (MD -0.60 g/L, 95% CI -1.54 to 0.35, 19 studies) and ferritin concentrations (MD -4.19 µg/L, 95% CI -9.42 to 1.05, 10 studies), but increased the risk of anaemia in comparison with daily iron supplementation (RR 1.23, 95% CI 1.04 to1.47, six studies). Data on adherence were scarce and it tended to be higher among those children receiving intermittent supplementation, although this result was not statistically significant.We did not identify any differential effect of the type of intermittent supplementation regimen (one, two or three times a week), the total weekly dose of elemental iron, the nutrient composition, whether recipients were male or female or the length of the intervention. AUTHORS' CONCLUSIONS: Intermittent iron supplementation is efficacious to improve haemoglobin concentrations and reduce the risk of having anaemia or iron deficiency in children younger than 12 years of age when compared with a placebo or no intervention, but it is less effective than daily supplementation to prevent or control anaemia. Intermittent supplementation may be a viable public health intervention in settings where daily supplementation has failed or has not been implemented. Information on mortality, morbidity, developmental outcomes and side effects, however, is still lacking.


Assuntos
Anemia Ferropriva/tratamento farmacológico , Desenvolvimento Infantil/efeitos dos fármacos , Suplementos Nutricionais , Ferro da Dieta/administração & dosagem , Anemia Ferropriva/sangue , Anemia Ferropriva/complicações , Criança , Fenômenos Fisiológicos da Nutrição Infantil/efeitos dos fármacos , Pré-Escolar , Esquema de Medicação , Feminino , Hemoglobinas Glicadas/metabolismo , Humanos , Masculino , Ensaios Clínicos Controlados Aleatórios como Assunto , Oligoelementos/administração & dosagem , Vitaminas/administração & dosagem
12.
J Int Med Res ; 38(2): 386-414, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20515554

RESUMO

With the progressive elimination of dietary protein-energy deficits, deficiencies of micronutrients are emerging as the limiting factors in ensuring children's optimal health. Data from several countries in Asia and Latin America indicate that deficiencies of vitamin C and zinc continue to be at alarming levels. This article reviews the roles of vitamin C and zinc in supporting children's growth and development, with a particular focus on the complementary roles they play in supporting immune functions and combating infections. The contemporary relevance of vitamin C and zinc deficiency in the Asian and Latin American regions, both undergoing a rapid nutritional transition, are also discussed. Overall, there is increasing evidence that deficiency of vitamin C and zinc adversely affects the physical and mental growth of children and can impair their immune defences. Nutrition should be the main vehicle for providing these essential nutrients; however, supplementation can represent a valid support method, especially in developing regions.


Assuntos
Antioxidantes/farmacologia , Ácido Ascórbico/farmacologia , Fenômenos Fisiológicos da Nutrição Infantil/efeitos dos fármacos , Sistema Imunitário/efeitos dos fármacos , Zinco/farmacologia , Ásia , Criança , Humanos , Oligoelementos/farmacologia
13.
Ann Trop Paediatr ; 30(1): 27-37, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20196931

RESUMO

BACKGROUND: In resource-limited countries, use of highly active antiretroviral therapy (HAART) in HIV-infected children is still poorly documented in terms of impact on survival, the immune system and growth. Since the availability of HAART, nutrition of HIV-infected children has been neglected. AIM: To evaluate the effect of HAART on survival and immune response in HIV-infected children and to investigate the response to nutritional support. METHODS: In December, 2002 a cohort study was carried out on vertically HIV-1-infected children and was observed longitudinally for CD4(+) T-cell count, antiretroviral treatment and weight until 31 December 2007. Z-scores were calculated for CD4(+) T-cell count to account for age-related differences. Nutritional supplementation was given to all the HIV-infected children and resting energy expenditure (REE) was calculated. Mortality rates were also calculated for the perinatally infected children followed up at the HIV clinic. RESULTS: A total of 180 children were assessed, 100 (56%) of whom were on HAART. Baseline body mass index was lower in the HAART group (p<0.05). Median duration of survival from date of diagnosis was 15.1 years. Those who received HAART survived significantly longer. The average annual mortality rate was 1.2% during 2005-2006. During HAART, a CD4 Z-score increase of 1 SD was associated with a 0.35 increase in body weight Z-score (p<0.001). The increase in daily energy intake owing to nutritional supplementation was associated with increase in weight Z-score in both the no-HAART and HAART group. REE was independently associated with weight change in the models which tested association of changes in CD4(+) T-cell Z-score and daily REE/kg body weight with changes in body weight Z-score in both the HAART and no-HAART group and then separately in the two groups (p<0.001). CONCLUSION: Survival rates of children improved which correlated with an increase in CD4(+) T-cell count concurrent with the expanded use of HAART. HAART had a positive effect on growth in HIV-1-infected children. Nutrition supplementation improved the health of children in both the no-HAART and HAART groups.


Assuntos
Fármacos Anti-HIV/uso terapêutico , Terapia Antirretroviral de Alta Atividade , Metabolismo Energético/efeitos dos fármacos , Infecções por HIV/tratamento farmacológico , Infecções por HIV/mortalidade , Aumento de Peso/efeitos dos fármacos , Contagem de Linfócito CD4 , Criança , Fenômenos Fisiológicos da Nutrição Infantil/efeitos dos fármacos , Pré-Escolar , Estudos de Coortes , Feminino , Infecções por HIV/virologia , HIV-1/isolamento & purificação , Humanos , Índia , Lactente , Transmissão Vertical de Doenças Infecciosas , Estudos Longitudinais , Masculino
14.
Appetite ; 54(2): 340-5, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20043963

RESUMO

The aim of this study was to determine the prevalence of dietary supplement use among Flemish preschoolers and to investigate associations between dietary supplement use and socio-economic variables of the parents. Parentally reported 3-day estimated dietary records (n=696) were used to calculate mean daily nutrient intakes, using Software for Intake Distribution Estimation (Cside). Socio-demographic information and frequency of dietary supplement use were collected via parental questionnaires, including a food frequency questionnaire (FFQ) (n=1847). The results from the FFQ revealed that more than 30% of the children used dietary supplements in the past month. Children of more highly educated parents and children of non-smokers were significantly more likely to use supplements than their counterparts. The types most frequently used were multi-vitamin/mineral supplements. Except for vitamin D, mean dietary intakes derived from foods alone was higher than the minimum recommendations for both supplement and non-supplement users. The youngest group of supplement users even exceeded the tolerable upper intake level for zinc (7 mg). However, for vitamin D, dietary supplements could help meet dietary recommendations for this micronutrient. In conclusion, the results indicated that dietary supplement use by healthy children who typically achieve their micronutrient requirements by foods alone could cause excessive intakes. Future studies should investigate potential harms and benefits of dietary supplementation use among preschoolers.


Assuntos
Fenômenos Fisiológicos da Nutrição Infantil/fisiologia , Dieta , Suplementos Nutricionais/estatística & dados numéricos , Minerais/administração & dosagem , Vitaminas/administração & dosagem , Bélgica , Criança , Fenômenos Fisiológicos da Nutrição Infantil/efeitos dos fármacos , Pré-Escolar , Análise por Conglomerados , Estudos Transversais , Registros de Dieta , Suplementos Nutricionais/efeitos adversos , Feminino , Humanos , Masculino , Inquéritos Nutricionais , Necessidades Nutricionais , Fatores Socioeconômicos , Inquéritos e Questionários
16.
Rev Endocr Metab Disord ; 9(3): 181-92, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18604643

RESUMO

Over one billion humans have insufficient circulating levels of vitamin D, and dietary insufficiency of calcium is common in developing countries. Worldwide, nutritional rickets is considered to be the most common non-communicable disease of children. Rickets can be due either to primary deficiencies of vitamin D or calcium or to combined deficiencies of both elements. Vitamin D deficiency is also increasingly linked to non-skeletal complications. Even without laboratory and radiologic resources, the diagnosis of rickets is considered clinically when a child presents with limb deformities and has beaded ribs and widened wrists and ankles. Prevention is possible through increased sun exposure and dietary enhancement. Treatment of nutritional rickets involves provision of adequate vitamin D and calcium. Further research is needed to elucidate the precise epidemiology of vitamin D and calcium deficiencies in developing countries, to determine the roles of additional pathologic factors contributing to the development and morbidity of rickets, to improve affordable and feasible means of diagnosing rickets in resource-limited areas, to better target at-risk populations for preventive interventions, to identify accurate dosing and delivery of therapeutic interventions, and to evaluate the long-term consequences of vitamin D and calcium deficiencies in childhood.


Assuntos
Cálcio/uso terapêutico , Países em Desenvolvimento , Suplementos Nutricionais , Deficiência de Vitamina D/terapia , Vitamina D/uso terapêutico , Criança , Fenômenos Fisiológicos da Nutrição Infantil/efeitos dos fármacos , Países em Desenvolvimento/estatística & dados numéricos , Humanos , Deficiência de Vitamina D/diagnóstico , Deficiência de Vitamina D/epidemiologia , Deficiência de Vitamina D/prevenção & controle
17.
Asia Pac J Clin Nutr ; 17 Suppl 1: 33-6, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18296296

RESUMO

Calcium is important for bone health. Over the last 15 years, reference calcium intakes in Western countries have been revised upwards for maximizing bone mass at skeletal maturity and for prevention of osteoporotic fractures. Some of these reference figures have also been adopted for use in Asian countries. However, the scientific data based on for revising reference calcium intakes in the West was largely based on Caucasians. Limited human studies relating to calcium requirements and bone mineralization have been conducted in Asians in Asia. In children and adolescents, a trial has confirmed no effects of calcium supplementation on bone gains in adolescent girls after 7 years. A meta-analysis has also revealed that calcium supplementation has little beneficial effects on bone gain. Given that genetic factors, hormonal status, body size, bone structure, diets, physical activity, vitamin D status and adaptation could modify calcium retention and bone integrity, these factors need to be considered collectively to promote bone health in Asian populations. Furthermore, studies to identify indigenous foods rich in calcium and high in bioavailability are needed to widen sources of dietary calcium. Ethnic differences in calcium retention, hormonal status, bone structure, bone mineral accretion and peak bone mass are evident among Asians, Caucasians and Blacks in USA. Hence, reference calcium intakes for Asians are likely to be unique and different from those of Caucasians. More research has to be conducted in Asian populations in order to develop appropriate reference calcium intakes for the region.


Assuntos
Conservadores da Densidade Óssea/administração & dosagem , Densidade Óssea/efeitos dos fármacos , Cálcio da Dieta/administração & dosagem , Fenômenos Fisiológicos da Nutrição Infantil/efeitos dos fármacos , Política Nutricional , Necessidades Nutricionais , Adolescente , Fenômenos Fisiológicos da Nutrição do Adolescente , Fatores Etários , Ásia/etnologia , Disponibilidade Biológica , Criança , Fenômenos Fisiológicos da Nutrição Infantil/fisiologia , Suplementos Nutricionais , Medicina Baseada em Evidências , Feminino , Humanos , Masculino
18.
Asia Pac J Clin Nutr ; 16 Suppl 2: 554-63, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17723995

RESUMO

Dietary supplement consumption practices among 2417 children (1295 boys and 1122 girls) aged 6 to 12 years in Taiwan were derived from the Nutrition and Health Survey in Taiwan Elementary School Children (NAHSIT 2001-2002). The proportion (22%) of boys and girls using supplements was equivalent. Some 77% of the child supplement takers took only one type of supplement. The top five supplements consumed were: multivitamins and minerals, calcium, vitamin C, cod-liver oil and bee propolis in that order. Children in the most urbanized southern Taiwan had the highest usage (33%), but prevalence was lowest in the mountainous areas (5%). Higher parental education level and household monthly income were associated with higher intakes. Supplement users were more competent at school; however, the frequency and number of supplement types were not related to competence.


Assuntos
Fenômenos Fisiológicos da Nutrição Infantil/efeitos dos fármacos , Cognição/efeitos dos fármacos , Suplementos Nutricionais/estatística & dados numéricos , Escolaridade , Renda , Criança , Fenômenos Fisiológicos da Nutrição Infantil/fisiologia , Cognição/fisiologia , Demografia , Feminino , Óleos de Peixe/administração & dosagem , Inquéritos Epidemiológicos , Humanos , Masculino , Minerais/administração & dosagem , Inquéritos Nutricionais , Taiwan , Vitaminas/administração & dosagem
19.
Am J Clin Nutr ; 86(4): 1082-93, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17921387

RESUMO

BACKGROUND: Little is known about the combined effect of micronutrients and essential fatty acids on cognitive function in school-aged children. OBJECTIVE: We assessed the effect of micronutrients, long-chain n-3 fatty acids, or both on indicators of cognitive performance in well-nourished and marginally nourished school-aged children. DESIGN: Two 2-by-2 factorial randomized controlled double-blind trials were performed home-based in Adelaide, South Australia, and at 6 primary schools in Jakarta, Indonesia. A total of 396 children (aged 6-10 y) in Australia and 384 children in Indonesia were randomly allocated to receive a drink with a micronutrient mix (iron, zinc, folate, and vitamins A, B-6, B-12, and C), with docosahexanoic acid (DHA, 88 mg/d) and eicosapentaenoic acid (EPA, 22 mg/d), or with both or placebo 6 d/wk for 12 mo. Biochemical indicators were determined at baseline and 12 mo. Cognitive performance was measured at baseline, 6 mo, and 12 mo. RESULTS: The micronutrient treatment significantly improved plasma micronutrient concentrations in Australian and Indonesian children. DHA+EPA treatment increased plasma DHA and total plasma n-3 fatty acids in both countries. The micronutrient treatment resulted in significant increases in scores on tests representing verbal learning and memory in Australia (estimated effect size: 0.23; 95% CI: 0.01, 0.46). A similar effect was observed among Indonesian girls (estimated effect size: 0.32; 95% CI: -0.01, 0.64). No effects were found on tests measuring general intelligence or attention. No effects of DHA+EPA on the factors of cognitive tests were observed. CONCLUSION: In well-nourished school-aged children, fortification with multiple micronutrients can result in improvements in verbal learning and memory.


Assuntos
Fenômenos Fisiológicos da Nutrição Infantil , Ácidos Graxos Ômega-3/administração & dosagem , Aprendizagem/efeitos dos fármacos , Memória/efeitos dos fármacos , Micronutrientes/administração & dosagem , Estado Nutricional , Atenção/efeitos dos fármacos , Austrália , Criança , Fenômenos Fisiológicos da Nutrição Infantil/efeitos dos fármacos , Fenômenos Fisiológicos da Nutrição Infantil/fisiologia , Método Duplo-Cego , Ácidos Graxos Essenciais/administração & dosagem , Ácidos Graxos Essenciais/metabolismo , Ácidos Graxos Ômega-3/metabolismo , Feminino , Alimentos Fortificados , Nível de Saúde , Humanos , Indonésia , Inteligência/efeitos dos fármacos , Masculino , Rememoração Mental/efeitos dos fármacos , Micronutrientes/metabolismo , Resultado do Tratamento
20.
Nutr J ; 6: 28, 2007 Sep 27.
Artigo em Inglês | MEDLINE | ID: mdl-17900364

RESUMO

BACKGROUND: Nutrients, hormones and growth factors in dairy foods may stimulate growth hormone (GH), insulin-like growth factor I (IGF-I), and raise the ratio of IGF-I to its binding protein, IGFBP-3. We conducted pilot studies in Mongolia and Massachusetts to test the extent to which milk intake raised somatotropic hormone concentrations in prepubertal children. METHODS: In Ulaanbaatar, we compared plasma levels before and after introducing 710 ml daily whole milk for a month among 46 10-11 year old schoolchildren. In a randomized cross-over study in Boston, we compared plasma hormone levels of 28 6-8 year old girls after one week of drinking 710 ml low fat (2%) milk with their hormone levels after one week of consuming a macronutrient substitute for milk. RESULTS: After a month of drinking whole milk, Mongolian children had higher mean plasma levels of IGF-I (p < 0.0001), IGF-I/IGFBP-3 (p < 0.0001), and 75th percentile of GH levels (p = 0.005). After a week of drinking low fat milk, Boston girls had small and non-significant increases in IGF-1, IGF-1/IGFBP-3 and GH. CONCLUSION: Milk drinking may cause increases in somatotropic hormone levels of prepubertal girls and boys. The finding that milk intake may raise GH levels is novel, and suggests that nutrients or bioactive factors in milk may stimulate endogenous GH production.


Assuntos
Desenvolvimento Infantil/efeitos dos fármacos , Fenômenos Fisiológicos da Nutrição Infantil/fisiologia , Hormônio do Crescimento/administração & dosagem , Hormônio do Crescimento/sangue , Leite/química , Animais , Criança , Fenômenos Fisiológicos da Nutrição Infantil/efeitos dos fármacos , Estudos Cross-Over , Gorduras na Dieta/farmacologia , Feminino , Hormônio do Crescimento Humano/sangue , Humanos , Proteína 3 de Ligação a Fator de Crescimento Semelhante à Insulina/sangue , Fator de Crescimento Insulin-Like I/metabolismo , Masculino , Projetos Piloto
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...